National and Kapodistrian University of Athens
Γενετικοί δείκτες απόπτωσης στην ιδιοπαθή φλεγμονώδη νόσο του εντέρου
Abstract
dc:descriptionAIM: To estimate the expression of p53, bax and bcl-2 genes in patients with inflammatory bowel disease and to compare their prognostic value with established clinical markers of prognosis. METHODS: Clinical, endoscopic, pathologic and therapeutic markers of prognosis were recorded in 27 patients with inflammatory bowel disease (10 with ulcerative colitis and 7 with Crohn's disease) in two consecutive colonoscopies with 1-2 years interval and in a 5 year follow up interview. Immunohistochemical staining of p53, bax and bcl-2 proteins was performed on paraffin-imbedded specimens taken from the patients and from a control group with colonic adenomas during the above sessions. The change of expression was compared between the two groups as well as with the prognostic indexes. RESULTS: After 2 years of follow up there was a significant improvement of the Modified Truelove and Witts Severity Index in patients with ulcerative colitis (p<0.001) and the Harvey Bradshaw Severity Index in patients with Crohn's disease (p=0.004). No significant changes were found in the endoscopic, pathologic and therapeutic score. Also, the expression of p53, bax and bcl-2 showed no significant difference between patients and controls in the 1st as well as in the 2nd session. The change of expression of the genes among patients was not significally different and the changes showed no correlation with the clinical, endoscopic, pathologic and therapeutic index of severity. Finally, 28% patients were operated in the end of the 5-year follow up and this was not influenced by the level of gene expression. CONCLUSION: There is no difference in the expression of the apoptosis related genes p53, bax and bcl-2 in patients with inflammatory bowel disease compared with other conditions related with apoptosis like colonic adenomas. Also, the expression of the apoptotic genes shows no correlation with the clinical course and probably the long-term prognosis of the disease. This implies that apoptosis and the genetic background play only a small role in the pathogenesis of inflammatory bowel disease with other factors (e.g. environmental/bacterial) having their part. Also, it implies that the evaluation of the patient's clinical picture is of great importance in long term treatment decisions
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2007
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Sfougatakis-Daskalakis, Nikolaos
- Σφουγκατάκης-Δασκαλάκης, Νικόλαος
Subjects
dc:subject × 17- Προγνωστικοί παράγοντες, Κλινικοί
- Ανοσοϊστοχημική χρώση βιοπτικού υλικού
- Κλινικοί δείκτες, Βελτίωση
- Γονίδια, Απουσία διαφοράς έκφρασης
- Απόπτωση, Μη σημαντικός ρόλος στην ΙΦΝΕ
- p53 genes
- Bax genes
- Bcl-2 genes
- Clinical prognostic markers
- Immunohistochemical stain of biopsics
- Clinical marker improvement
- No diference in gene expression
- No important role of apoptosis in IBD
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/23439